• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 21-25, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 21-25, 2010
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/21/10Silver Spring, MDJoshua Sharfstein, Theresa Mull, Jeff O’Neill James Greenwood, Sara Radcliffe, Richard Pops, Stephanie Sherwin (Biotechnology Industry Organization); Billy Tauzin, David Wheadon, Kevin Sharer (Pharmaceutical Research Manufacturers of America)Goals for the performance of FDA’s human drug review program
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/21/10Silver Spring, MDJesse Goodman, Ralph Tyler, Jeanne Ireland, Michael Taylor, Jessica Leighton, Peter Lurie, Barbara Schneeman, Benson Silverman, Catherine Copp, Mitchell Cheeseman, Kristy Moran, Sylvia Kim, Ashley RileyDouglas Greenaway, Tae Chong (National WIC Association); Bob Greenstein, Zoe Neuberger, Meredith McGehee (California WIC Association)Food additives and label claims
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/23/10Little Rock, ARWilliam Slikker, Jr.N/AMeeting with representatives from academia, industry, and state offices regarding how Arkansas' interests and other resources can be used to better support FDA and develop partnerships
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/21/10Norfolk, VA N/AAttendees at the ConferenceSpeech at Association of Food & Drug Officials 114th Annual Educational Conference
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/22/10Silver Spring, MD Jesse GoodmanEmil Kakkis (Kakkis EveryLife Foundation); Sara Weir (B&D Consulting)Science and the review of drugs for rare metabolic disorders
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/25/10Washington, DCKristina Harper, Benjamin GutmanEric Schwaab, Steve Murawski (National Oceanic and Atmospheric Administration); Senator Barbara Mikulski, Senator Ben Cardin,  Congressman Roscoe Bartlett, Congressman John Sarbanes, Congressman Frank Kratovil, Congressman Charles Albert Dutch Ruppersberger III, Congresswoman Donna Edwards Gulf oil spill impact on Maryland 
Russell Abbott, Deputy Commissioner for Administration6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/24/10Rockville, MDN/AJoel Newman (American Feed Industry Association)Quarterly Meeting
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/24/10Silver Spring, MDDavid Dorsey, Jesse Goodman, Tania Simoncelli, Mac Holt, Wanda Russ, Michelle DifilippoTracie Letterman, Andrew Rowan, Sara Amundson, Mary Lou Randour (The Humane Society of the United States) Alternatives to Animal Testing and the Human Animal Bond
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/21/10Silver Spring, MDLuciana Borio, Leonard SacksThomas Bollyky, Sarah Jane Staats (Center for Global Development)Upcoming Senate Hearing
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/21/10Silver Spring, MDKaren MidthunBrian McNamee, Andrew Cuthbertson, Dennis Jackman (CSL Behring) Trivalent Influenza Vaccine in Australia
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/22/10Norfolk, VAN/AN/ASpeech: AFDO 114th Annual Educational Conference
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/23/10Bethesda, MDN/AVincent Ahonkhai (Bill & Melinda Gates Foundation)International Issues
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/24/10Washington, DCN/ASteve MacMillan (Stryker Corporation)International Issues
Beth Martino, Associate Commissioner for External Affairs6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research6/21/10-6/25/10N/AN/AN/ANo Significant Meetings 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/21/10-6/25/10 N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/21/10-6/25/10N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/24/10New Orleans, LADonald Kraemer, John Veazy, Patricia SchaferHarold Jaffe, Scott Deitchman (Centers for Disease Control and Prevention); Shawn McGrath, Steve Wilson (National Oceanic and Atmospheric Administration); Lisa Kaplowitz (Health and Human Services);  Paul Anastas, Mathy Stanislaus (Enviornmental Protection Agency);  Eric Schwaab (National Marine Fisheries Service); Jimmy Guidry, Myran Fischer (State of Louisiana); Ana Viamonte Ros, Russ Eggert (State of Florida); Bruce Clements (State of Texas); Mary Currier, Dale Diaz (State of Mississippi); Donald Williamson, Chris Denson (State of Alabama); Jim Blumenstock (Association of State and Territorial Health Officials)Working lunch with NOAA, FDA, Fisheries & Wildlife, and State Health Officers regarding oil-impacted areas closed to seafood harvesting
Ralph Tyler, J.D., Chief Counsel6/21/10Silver Spring, MDDaniel Sigelman, Lynn Mehler, Wendy Vicente, Eric Blumberg, Elizabeth DickinsonBill Curtis (Miller, Curtis, Weisberg); Daniel McGlynn (McClynn, Glysson & Mouton); Louis Bograd (Center for Constitutional Litigation); Mike Johnson (Goldenberg & Johnson); Claire Prestel (Public Justice PC)Generic Preemption
Ralph Tyler, J.D., Chief Counsel6/22/10Silver Spring, MDElizabeth Dickinson, Wendy Vicente, Eric Blumberg, Lynn Mehler, Daniel SigelmanJoe Thomas (Ulmer & Berne); Michael Shumsky (Kirkland & Ellis); Brian Rubenstein (TEVA)Generic Preemption
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/21/10WebinarMichael Ortwerth, Andrea Furia-HelmsPatient Representatives for Advisory CommitteesConflict of Interest
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/24/10Washington, DCN/ADan Leonard (National Pharmaceutical Council); Gail Wilensky (Project HOPE/Health Affairs) Shaping Convergent Strategies in Comparative Effectiveness Research
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/24/10Washington, DCN/ARaymond Bartus (Ceregene, Inc.); Story Landis (NINDS)Emerging Therapies:  From Microscope to Marketplace Interactive Webcast